Age-dependent changes in vancomycin-induced nephrotoxicity in mice

Vancomycin hydrochloride (VCM) is a glycopeptide antibiotic that is commonly used to eradicate methicillin-resistant gram-positive cocci, despite its nephrotoxic side effects. Elderly people are particularly susceptible to developing VCM-induced nephrotoxicity. However, the precise mechanism by which VCM induces nephrotoxicity in elderly people is not completely understood. Therefore, we investigated VCM-induced nephrotoxicity in mice of different ages. VCM was injected intraperitoneally into mice at 1, 3, 6, 12, and 24 months of age at a dosage of 400 mg/kg body weight for 3 and 14 days. Twenty-four hours after the last injection, we examined plasma creatinine levels and histopathological alterations in the kidneys. VCM administration increased plasma creatinine levels, and these values gradually increased to higher levels with aging. The histological examination revealed renal tubular degeneration, such as brush-border atrophy, apoptosis/necrosis of the tubular epithelium, and epithelial desquamation, that gradually became more severe with aging. Furthermore, immunohistochemical staining with anti-CD10 and anti-single-stranded DNA antibodies revealed damaged renal proximal tubules with marked dilatation, as well as numerous apoptotic cells, and these features increased in severity in 12- and 24-month-old mice receiving VCM. Based on these results, aged mice were highly susceptible to kidney damage induced by VCM administration. In addition, proximal tubular epithelial cells likely underwent apoptosis after the administration of VCM. This report is the first to document VCM-induced nephrotoxicity in mice of different ages. Thus, this mouse model could be useful for understanding the mechanisms of VCM-induced nephrotoxicity in the elderly.

[1]  Jaewon Lee,et al.  Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice. , 2017, Biological & pharmaceutical bulletin.

[2]  T. Yano,et al.  Vancomycin induces reactive oxygen species‐dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells , 2017, European journal of pharmacology.

[3]  R. Sawyer,et al.  Vancomycin-Associated Nephrotoxicity: The Obesity Factor. , 2015, Surgical infections.

[4]  Katsunori Furuta,et al.  Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia , 2013, Clinical interventions in aging.

[5]  A. Nishikawa,et al.  Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System , 2012, Toxicologic pathology.

[6]  T. Yano,et al.  Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. , 2012, Free radical biology & medicine.

[7]  Geoffrey S. Teehan,et al.  Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis , 2012, Clinical and Experimental Nephrology.

[8]  L. Truong,et al.  Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? , 2012, Archives of pathology & laboratory medicine.

[9]  H. Khalili,et al.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review , 2012, European Journal of Clinical Pharmacology.

[10]  H. Sokol,et al.  Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Y. Kagawa,et al.  Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. , 2003, Biological & pharmaceutical bulletin.

[12]  K. Rodvold,et al.  Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children , 1997, Clinical pharmacokinetics.

[13]  J. Fortún,et al.  The comparative efficacy and safety of teicoplanin and vancomycin. , 1996, The Journal of antimicrobial chemotherapy.

[14]  M. Lindstrom,et al.  Risk of Nephrotoxicity with Combination Vancomycin‐Aminoglycoside Antibiotic Therapy , 1990, Pharmacotherapy.

[15]  C. A. Wood,et al.  Vancomycin enhancement of experimental tobramycin nephrotoxicity , 1986, Antimicrobial Agents and Chemotherapy.

[16]  D. Levine,et al.  Vancomycin: a history. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  I. Naruse,et al.  Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis , 2004, Histochemistry.

[18]  Gary A. Boorman,et al.  Pathology of the Mouse: Reference and Atlas , 1999 .